NEW YORK -- Johnson & Johnson is leveraging its technologies used in the development of vaccines for Ebola, Zika, and HIV in a race to stop the spread of COVID-19, the illness caused by the new coronavirus.
The deadly outbreak has galvanized researchers across the globe, and countries and companies are rushing find treatments and develop a vaccine as the death toll rises. On Tuesday, the Chinese government said an influenza medicine, Avigan, developed by a group company of Japan's Fujifilm Holdings, is effective against the coronavirus.
